1 Introduction to Research & Analysis Reports
1.1 Biosimilars & Follow-on-Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilars & Follow-on-Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilars & Follow-on-Biologics Overall Market Size
2.1 Global Biosimilars & Follow-on-Biologics Market Size: 2022 VS 2029
2.2 Global Biosimilars & Follow-on-Biologics Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Biosimilars & Follow-on-Biologics Sales: 2018-2029
3 Company Landscape
3.1 Top Biosimilars & Follow-on-Biologics Players in Global Market
3.2 Top Global Biosimilars & Follow-on-Biologics Companies Ranked by Revenue
3.3 Global Biosimilars & Follow-on-Biologics Revenue by Companies
3.4 Global Biosimilars & Follow-on-Biologics Sales by Companies
3.5 Global Biosimilars & Follow-on-Biologics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Biosimilars & Follow-on-Biologics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Biosimilars & Follow-on-Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biosimilars & Follow-on-Biologics Players in Global Market
3.8.1 List of Global Tier 1 Biosimilars & Follow-on-Biologics Companies
3.8.2 List of Global Tier 2 and Tier 3 Biosimilars & Follow-on-Biologics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Biosimilars & Follow-on-Biologics Market Size Markets, 2022 & 2029
4.1.2 Human Growth Hormone
4.1.3 Erythropoietin
4.1.4 Monoclonal Antibodies
4.1.5 Insulin
4.1.6 Interferon
4.1.7 Granulocyte-Colony Stimulating Factor
4.1.8 Peptide
4.1.9 Others
4.2 By Type – Global Biosimilars & Follow-on-Biologics Revenue & Forecasts
4.2.1 By Type – Global Biosimilars & Follow-on-Biologics Revenue, 2018-2023
4.2.2 By Type – Global Biosimilars & Follow-on-Biologics Revenue, 2024-2029
4.2.3 By Type – Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
4.3 By Type – Global Biosimilars & Follow-on-Biologics Sales & Forecasts
4.3.1 By Type – Global Biosimilars & Follow-on-Biologics Sales, 2018-2023
4.3.2 By Type – Global Biosimilars & Follow-on-Biologics Sales, 2024-2029
4.3.3 By Type – Global Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
4.4 By Type – Global Biosimilars & Follow-on-Biologics Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Biosimilars & Follow-on-Biologics Market Size, 2022 & 2029
5.1.2 Blood Disorders
5.1.3 Oncology Diseases
5.1.4 Chronic and Autoimmune Diseases
5.1.5 Growth Hormone Deficiencies
5.1.6 Others
5.2 By Application – Global Biosimilars & Follow-on-Biologics Revenue & Forecasts
5.2.1 By Application – Global Biosimilars & Follow-on-Biologics Revenue, 2018-2023
5.2.2 By Application – Global Biosimilars & Follow-on-Biologics Revenue, 2024-2029
5.2.3 By Application – Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
5.3 By Application – Global Biosimilars & Follow-on-Biologics Sales & Forecasts
5.3.1 By Application – Global Biosimilars & Follow-on-Biologics Sales, 2018-2023
5.3.2 By Application – Global Biosimilars & Follow-on-Biologics Sales, 2024-2029
5.3.3 By Application – Global Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
5.4 By Application – Global Biosimilars & Follow-on-Biologics Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Biosimilars & Follow-on-Biologics Market Size, 2022 & 2029
6.2 By Region – Global Biosimilars & Follow-on-Biologics Revenue & Forecasts
6.2.1 By Region – Global Biosimilars & Follow-on-Biologics Revenue, 2018-2023
6.2.2 By Region – Global Biosimilars & Follow-on-Biologics Revenue, 2024-2029
6.2.3 By Region – Global Biosimilars & Follow-on-Biologics Revenue Market Share, 2018-2029
6.3 By Region – Global Biosimilars & Follow-on-Biologics Sales & Forecasts
6.3.1 By Region – Global Biosimilars & Follow-on-Biologics Sales, 2018-2023
6.3.2 By Region – Global Biosimilars & Follow-on-Biologics Sales, 2024-2029
6.3.3 By Region – Global Biosimilars & Follow-on-Biologics Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Biosimilars & Follow-on-Biologics Revenue, 2018-2029
6.4.2 By Country – North America Biosimilars & Follow-on-Biologics Sales, 2018-2029
6.4.3 US Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.4.4 Canada Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.4.5 Mexico Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Biosimilars & Follow-on-Biologics Revenue, 2018-2029
6.5.2 By Country – Europe Biosimilars & Follow-on-Biologics Sales, 2018-2029
6.5.3 Germany Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.4 France Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.5 U.K. Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.6 Italy Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.7 Russia Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.8 Nordic Countries Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.5.9 Benelux Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Biosimilars & Follow-on-Biologics Revenue, 2018-2029
6.6.2 By Region – Asia Biosimilars & Follow-on-Biologics Sales, 2018-2029
6.6.3 China Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.6.4 Japan Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.6.5 South Korea Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.6.6 Southeast Asia Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.6.7 India Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Biosimilars & Follow-on-Biologics Revenue, 2018-2029
6.7.2 By Country – South America Biosimilars & Follow-on-Biologics Sales, 2018-2029
6.7.3 Brazil Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.7.4 Argentina Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Biosimilars & Follow-on-Biologics Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Biosimilars & Follow-on-Biologics Sales, 2018-2029
6.8.3 Turkey Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.8.4 Israel Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.8.5 Saudi Arabia Biosimilars & Follow-on-Biologics Market Size, 2018-2029
6.8.6 UAE Biosimilars & Follow-on-Biologics Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Biosimilars & Follow-on-Biologics Major Product Offerings
7.1.4 Novartis Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Synthon Pharmaceuticals
7.2.1 Synthon Pharmaceuticals Company Summary
7.2.2 Synthon Pharmaceuticals Business Overview
7.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Major Product Offerings
7.2.4 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.2.5 Synthon Pharmaceuticals Key News & Latest Developments
7.3 Teva Pharmaceutical Industries
7.3.1 Teva Pharmaceutical Industries Company Summary
7.3.2 Teva Pharmaceutical Industries Business Overview
7.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Major Product Offerings
7.3.4 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.3.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.4 LG Life Sciences
7.4.1 LG Life Sciences Company Summary
7.4.2 LG Life Sciences Business Overview
7.4.3 LG Life Sciences Biosimilars & Follow-on-Biologics Major Product Offerings
7.4.4 LG Life Sciences Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.4.5 LG Life Sciences Key News & Latest Developments
7.5 Celltrion
7.5.1 Celltrion Company Summary
7.5.2 Celltrion Business Overview
7.5.3 Celltrion Biosimilars & Follow-on-Biologics Major Product Offerings
7.5.4 Celltrion Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.5.5 Celltrion Key News & Latest Developments
7.6 Biocon
7.6.1 Biocon Company Summary
7.6.2 Biocon Business Overview
7.6.3 Biocon Biosimilars & Follow-on-Biologics Major Product Offerings
7.6.4 Biocon Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.6.5 Biocon Key News & Latest Developments
7.7 Hospira
7.7.1 Hospira Company Summary
7.7.2 Hospira Business Overview
7.7.3 Hospira Biosimilars & Follow-on-Biologics Major Product Offerings
7.7.4 Hospira Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.7.5 Hospira Key News & Latest Developments
7.8 Merck Group
7.8.1 Merck Group Company Summary
7.8.2 Merck Group Business Overview
7.8.3 Merck Group Biosimilars & Follow-on-Biologics Major Product Offerings
7.8.4 Merck Group Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.8.5 Merck Group Key News & Latest Developments
7.9 Biogen idec, Inc.
7.9.1 Biogen idec, Inc. Company Summary
7.9.2 Biogen idec, Inc. Business Overview
7.9.3 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Major Product Offerings
7.9.4 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.9.5 Biogen idec, Inc. Key News & Latest Developments
7.10 Genentech (Roche Group)
7.10.1 Genentech (Roche Group) Company Summary
7.10.2 Genentech (Roche Group) Business Overview
7.10.3 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Major Product Offerings
7.10.4 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Sales and Revenue in Global (2018-2023)
7.10.5 Genentech (Roche Group) Key News & Latest Developments
8 Global Biosimilars & Follow-on-Biologics Production Capacity, Analysis
8.1 Global Biosimilars & Follow-on-Biologics Production Capacity, 2018-2029
8.2 Biosimilars & Follow-on-Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Biosimilars & Follow-on-Biologics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biosimilars & Follow-on-Biologics Supply Chain Analysis
10.1 Biosimilars & Follow-on-Biologics Industry Value Chain
10.2 Biosimilars & Follow-on-Biologics Upstream Market
10.3 Biosimilars & Follow-on-Biologics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biosimilars & Follow-on-Biologics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のバイオシミラー&バイオ後続品市場予測2023-2029：ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、ペプチド、その他 |
| 【英語タイトル】Biosimilars & Follow-on-Biologics Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5717 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：72 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のバイオシミラー&バイオ後続品市場規模と予測を収録しています。・世界のバイオシミラー&バイオ後続品市場：売上、2018年-2023年、2024年-2029年 ・世界のバイオシミラー&バイオ後続品市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のバイオシミラー&バイオ後続品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ヒト成長ホルモン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 バイオシミラー&バイオ後続品のグローバル主要企業は、Novartis、 Synthon Pharmaceuticals、 Teva Pharmaceutical Industries、 LG Life Sciences、 Celltrion、 Biocon、 Hospira、 Merck Group、 Biogen idec, Inc.、 Genentech (Roche Group)などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、バイオシミラー&バイオ後続品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のバイオシミラー&バイオ後続品市場：タイプ別、2018年-2023年、2024年-2029年 世界のバイオシミラー&バイオ後続品市場：タイプ別市場シェア、2022年 ・ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、ペプチド、その他 世界のバイオシミラー&バイオ後続品市場：用途別、2018年-2023年、2024年-2029年 世界のバイオシミラー&バイオ後続品市場：用途別市場シェア、2022年 ・血液疾患、腫瘍疾患、慢性&自己免疫疾患、成長ホルモン欠乏症、その他 世界のバイオシミラー&バイオ後続品市場：地域・国別、2018年-2023年、2024年-2029年 世界のバイオシミラー&バイオ後続品市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるバイオシミラー&バイオ後続品のグローバル売上、2018年-2023年 ・主要企業におけるバイオシミラー&バイオ後続品のグローバル売上シェア、2022年 ・主要企業におけるバイオシミラー&バイオ後続品のグローバル販売量、2018年-2023年 ・主要企業におけるバイオシミラー&バイオ後続品のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Novartis、 Synthon Pharmaceuticals、 Teva Pharmaceutical Industries、 LG Life Sciences、 Celltrion、 Biocon、 Hospira、 Merck Group、 Biogen idec, Inc.、 Genentech (Roche Group) ************************************************************* ・調査・分析レポートの概要 バイオシミラー&バイオ後続品市場の定義 市場セグメント 世界のバイオシミラー&バイオ後続品市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のバイオシミラー&バイオ後続品市場規模 世界のバイオシミラー&バイオ後続品市場規模：2022年 VS 2029年 世界のバイオシミラー&バイオ後続品市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのバイオシミラー&バイオ後続品の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のバイオシミラー&バイオ後続品製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、ペプチド、その他 バイオシミラー&バイオ後続品のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：血液疾患、腫瘍疾患、慢性&自己免疫疾患、成長ホルモン欠乏症、その他 バイオシミラー&バイオ後続品の用途別グローバル売上・予測 ・地域別市場分析 地域別バイオシミラー&バイオ後続品市場規模 2022年と2029年 地域別バイオシミラー&バイオ後続品売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Novartis、 Synthon Pharmaceuticals、 Teva Pharmaceutical Industries、 LG Life Sciences、 Celltrion、 Biocon、 Hospira、 Merck Group、 Biogen idec, Inc.、 Genentech (Roche Group) ... |
This report aims to provide a comprehensive presentation of the global market for Biosimilars & Follow-on-Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilars & Follow-on-Biologics. This report contains market size and forecasts of Biosimilars & Follow-on-Biologics in global, including the following market information:
Global Biosimilars & Follow-on-Biologics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Biosimilars & Follow-on-Biologics Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Biosimilars & Follow-on-Biologics companies in 2022 (%)
The global Biosimilars & Follow-on-Biologics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Human Growth Hormone Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Biosimilars & Follow-on-Biologics include Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group and Biogen idec, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Biosimilars & Follow-on-Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilars & Follow-on-Biologics Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Biosimilars & Follow-on-Biologics Market Segment Percentages, by Type, 2022 (%)
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
Global Biosimilars & Follow-on-Biologics Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Biosimilars & Follow-on-Biologics Market Segment Percentages, by Application, 2022 (%)
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Global Biosimilars & Follow-on-Biologics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Biosimilars & Follow-on-Biologics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilars & Follow-on-Biologics revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Biosimilars & Follow-on-Biologics revenues share in global market, 2022 (%)
Key companies Biosimilars & Follow-on-Biologics sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Biosimilars & Follow-on-Biologics sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)
Outline of Major Chapters:
Chapter 1: Introduces the definition of Biosimilars & Follow-on-Biologics, market overview.
Chapter 2: Global Biosimilars & Follow-on-Biologics market size in revenue and volume.
Chapter 3: Detailed analysis of Biosimilars & Follow-on-Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biosimilars & Follow-on-Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Biosimilars & Follow-on-Biologics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のバイオシミラー&バイオ後続品市場予測2023-2029：ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、ペプチド、その他] (コード：MMG23JU5717)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のバイオシミラー&バイオ後続品市場予測2023-2029：ヒト成長ホルモン、エリスロポエチン、モノクローナル抗体、インスリン、インターフェロン、顆粒球コロニー刺激因子、ペプチド、その他]についてメールでお問い合わせ |
